CTi Biopharma Correlations

Summary

CTICDelisted Stock

USD 9.09 0.00 0.00%

The current 90-days correlation between CTi Biopharma Corp and Rigel Pharmaceuticals is -0.03 (i.e., Good diversification). The correlation of CTi Biopharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

Moving together with CTi Stock

0.74	KB	KB Financial Group	Pair Corr
0.74	CVX	Chevron Corp Fiscal Year End 7th of February 2025	Pair Corr
0.75	JPM	JPMorgan Chase Fiscal Year End 10th of January 2025	Pair Corr
0.69	CAT	Caterpillar Fiscal Year End 3rd of February 2025	Pair Corr
0.92	CSCO	Cisco Systems Aggressive Push	Pair Corr
0.82	TRV	The Travelers Companies Fiscal Year End 17th of January 2025	Pair Corr
0.81	BAC	Bank of America Fiscal Year End 10th of January 2025	Pair Corr
0.8	HPQ	HP Inc	Pair Corr
0.77	WMT	Walmart Aggressive Push	Pair Corr
0.78	AXP	American Express Fiscal Year End 24th of January 2025	Pair Corr
0.86	AA	Alcoa Corp Fiscal Year End 15th of January 2025	Pair Corr

Moving against CTi Stock

0.86	EC	Ecopetrol SA ADR	Pair Corr
0.86	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.73	TLK	Telkom Indonesia Tbk	Pair Corr
0.68	HYMTF	Hyundai Motor	Pair Corr
0.66	SHG	Shinhan Financial	Pair Corr
0.63	BA	Boeing Fiscal Year End 29th of January 2025	Pair Corr
0.61	JNJ	Johnson Johnson Sell-off Trend	Pair Corr
0.55	PFE	Pfizer Inc Aggressive Push	Pair Corr
0.49	VFSWW	VinFast Auto	Pair Corr
0.47	TCHH	Trustcash Holdings	Pair Corr
0.42	WF	Woori Financial Group	Pair Corr
0.32	MMM	3M Company Fiscal Year End 28th of January 2025	Pair Corr

Related Correlations Analysis

	RIGL	FBIO	RVPH	OCUP	PLX	MCRB	CDTX	IBRX	GRTX
RIGL		-0.47	0.05	-0.43	0.77	-0.58	0.64	0.45	-0.33	RIGL
FBIO	-0.47		-0.39	0.64	-0.37	0.02	0.06	0.13	-0.25	FBIO
RVPH	0.05	-0.39		-0.26	0.0	0.32	-0.33	-0.5	0.42	RVPH
OCUP	-0.43	0.64	-0.26		-0.46	0.15	-0.02	-0.18	-0.22	OCUP
PLX	0.77	-0.37	0.0	-0.46		-0.42	0.78	0.57	-0.28	PLX
MCRB	-0.58	0.02	0.32	0.15	-0.42		-0.46	-0.59	0.53	MCRB
CDTX	0.64	0.06	-0.33	-0.02	0.78	-0.46		0.67	-0.61	CDTX
IBRX	0.45	0.13	-0.5	-0.18	0.57	-0.59	0.67		-0.62	IBRX
GRTX	-0.33	-0.25	0.42	-0.22	-0.28	0.53	-0.61	-0.62		GRTX
	RIGL	FBIO	RVPH	OCUP	PLX	MCRB	CDTX	IBRX	GRTX

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

CDTX	+ 0.78	PLX
PLX	+ 0.77	RIGL
IBRX	+ 0.67	CDTX
CDTX	+ 0.64	RIGL
OCUP	+ 0.64	FBIO
IBRX	+ 0.57	PLX

High negative correlations

GRTX	- 0.62	IBRX
GRTX	- 0.61	CDTX
IBRX	- 0.59	MCRB
MCRB	- 0.58	RIGL
IBRX	- 0.5	RVPH
FBIO	- 0.47	RIGL

Risk-Adjusted Indicators

There is a big difference between CTi Stock performing well and CTi Biopharma Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze CTi Biopharma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
RIGL	3.53	1.07	0.37	0.58	2.44	(4.45)	9.10	(4.39)	55.18
FBIO	3.05	(0.47)	0.00	(0.23)	0.00	0.00	7.43	(5.08)	26.13
RVPH	4.89	0.70	0.07	(0.60)	5.88	(5.63)	10.71	(9.86)	38.61
OCUP	3.18	(0.74)	0.00	5.87	0.00	0.00	6.10	(5.84)	27.18
PLX	3.22	1.07	0.26	(1.42)	2.54	(4.31)	10.00	(5.56)	20.38
MCRB	4.68	0.01	(0.02)	0.25	5.68	(5.36)	10.00	(9.78)	28.84
CDTX	2.65	0.68	0.26	1.27	2.07	(3.65)	7.38	(3.77)	17.09
IBRX	4.33	0.33	0.08	0.37	4.45	(5.26)	13.00	(7.80)	35.54
GRTX	2.93	0.05	0.00	0.04	0.00	0.00	7.31	(5.84)	18.16

View CTi Biopharma Related Equities

Rigel Pharmaceuticals Fortress Biotech Reviva Pharmaceuticals Holdings Ocuphire Pharma Protalix Biotherapeutics Seres Therapeutics Cidara Therapeutics Immunitybio Galera Therapeutics Paratek Pharmaceuticals Corvus Pharmaceuticals Immutep Ltd ADR Icosavax Verastem ImmunoGen

Risk & Return

Correlation

CTi Biopharma Corporate Management

Jennifer Smith	VP Biometrics	Profile
James Fong	Ex Officer	Profile
Bruce Bennett	VP Operations	Profile
John Volpone	Ex Staff	Profile
MBA MD	CEO and President	Profile

Still Interested in CTi Biopharma Corp?

Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC